diclofenac sodium gel
e. fougera & co. a division of fougera pharmaceuticals inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium. diclofenac sodium gel is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.
diclofenac sodium gel
ipg pharmaceuticals, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium. diclofenac sodium gel is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.
diclofenac sodium gel
lake erie medical dba quality care products llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or sodium hyaluronate. diclofenac sodium gel is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.
hyvisc- hyaluronate sodium injection
boehringer ingelheim animal health usa inc. - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - hyvisc (hyaluronate sodium) injection is recommended for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis. there are no known contraindications to the use of hyvisc (hyaluronate sodium) injection.
diclofenac sodium- diclofenac sodium gel
remedyrepack inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel, 3% is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel, 3% is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol and/or polyethylene glycol monomethyl ether 350. diclofenac sodium gel, 3% is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.
sodium hyaluronate
vetoquinol australia pty ltd - sodium hyaluronate - unknown - sodium hyaluronate ungrouped active 0.0 - active constituent
sodium hyaluronate
boehringer ingelheim animal health australia pty. ltd. - sodium hyaluronate - unknown - sodium hyaluronate ungrouped active 0.0 - active constituent
viscoat injection
alcon laboratories s a (pty) ltd waterfall city, magwa crescent, jukskeipark, - sodium hyaluronate & sodium chondroitin sulphate - injection - each 1ml contains 30 mg sodium hyaluronate & 40 - surgical aids: viscoelasticsubstances
ax pharmaceutical corp- hyaluronate acid sodium powder
ax pharmaceutical corp - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - hyaluronate sodium 247.5 g in 250 g
equinate injection
randlab australia pty ltd - sodium hyaluronate - parenteral liquid/solution/suspension - sodium hyaluronate ungrouped active 10.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - non-infectious acute synovitis